Thyroid hormone residues are released from thyroglobulin with only limited alteration of the thyroglobulin structure

We have tried to characterize thyroglobulin (Tg) degradation products in purified pig thyroid lysosomes to determine whether the release of thyroid hormone residues from Tg involves a random proteolytic attack or discrete and selective cleavage reactions. The intralysosomal soluble protein fraction was prepared by osmotic pressure-dependent lysis of lysosomes purified by isopycnic centrifugation on Percoll gradients. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate revealed the presence of a fraction of Tg (5-10% of total lysosomal protein) with the same molecular weight as that of the intact Tg subunit. This high molecular weight Tg was the only intralysosomal species detected by Western blot using antipig Tg antibodies. In nondenaturing conditions, lysosomal Tg (LTg) identified by radioimmunoassay was in the form of a dimer with a sedimentation coefficient lower than that of either iodinated Tg (colloid Tg) or noniodinated Tg (microsomal Tg). LTg had a lower iodine content than colloid Tg:9-12 versus 39-42 iodine atoms/molecule. Pronase hydrolysates of LTg did not contain any 3,5,3',5'-tetraiodo-L-thyronine or 3,3',5-triiodo-L-thyronine residues detectable by reverse-phase high pressure liquid chromatography; iodine present in LTg was in the form of iodotyrosines. Under reducing conditions, LTg almost completely disappeared and gave rise to various polypeptides of smaller size. These results suggest that Tg transferred to lysosomes is subjected to selective proteolytic cleavage reaction(s) that release thyroid hormone residues. This early step would lead to the formation of hormone-depleted Tg molecules that are cleaved at discrete sites, the resulting polypeptides remaining bound through disulfide bonds to yield Tg molecules with an apparently normal size and a slightly altered structure.

Thyroid function in embryonic and early posthatch chickens and quail

Technological advances, especially radioimmunoassays, have led to good descriptive information about the timing and pattern of development of the thyroid gland (TG) and circulating thyroid hormone (TH). Immunocytochemical studies in combination with more traditional techniques such as gland ablation and hormone replacement have revealed the time of appearance of each hormone in the axis, the relative amounts of hormone present in each gland at different developmental stages, and a general picture of the pattern of maturation of the hypothalamic-pituitary-thyroid axis. Studies of the pituitary control of the TG remain limited by the lack of adequately specific techniques for measuring avian thyroid-stimulating hormone. Our understanding of peripheral TH dynamics is progressing as a result of iodothyronine deiodinase assays but full understanding will require more elaborate studies that adequately characterize the enzyme system(s) in each case. Molecular techniques have made powerful strides in identifying the gene responsible for producing a protein that appears to be the triiodothyronine receptor. Receptor assays have revealed the pattern of changes in receptor-binding capacities during development but have not yet revealed how binding of hormone to the receptor triggers cellular activity. Molecular genetic techniques are being used to reveal the mechanisms whereby some examples of developmental events (e.g., malic enzyme synthesis) are induced by TH. Although it is not yet possible to assess the value of molecular studies in this area for developing practical applications, these techniques are revealing the fundamental biological roles of TH in growth and development.

[Role of sex dimorphism in the pharmacological action of etimizol]

It has been shown that in female rats the level of ACTH, corticosterone in the blood, relative mass of adrenals, maintenance of T3, T4 in the serum and liver was significantly higher, but the activity of liver enzyme microsomes system was lower than in males; no sex differences were observed in myocardial creatine phosphokinase system. The influence of the etimizol on the female rats significantly speed up amidopyrine N-demethylation and biotransformation of hexobarbital. In males these systems react less on etimizol, but it reduces the speed of amidopyrine N-demethylation.

Isolation and characterization of hagfish thyroid iodoprotein by its non-thyroglobulin nature, very high iodine and carbohydrate contents and low hormone/iodine ratio

We have characterized the thyroid iodoprotein of a hagfish, Eptatretus burgeri, one of the lowest marine vertebrates. The iodoprotein was not very homogeneous in its apparent molecular mass which decreased with the increase in hormone/iodotyrosine ratio. Four subfractions with an apparent molecular mass of about 400 kDa were purified from one major fraction by size-exclusion and Mono Q ion-exchange HPLC. The subfractions appeared to have the same peptide backbone, since they showed a single band with the same mobility as a 160-kDa protein in SDS/PAGE and the same amino acid composition. However they differed from each other in having increasing iodine contents (1.9% to 5.9% by mass of total amino acids) associated with the increase in hormonal iodine proportion (8.4% to 16.7% of total iodine) and carbohydrate content (35.6% to 53.5% by mass). These values are strikingly different from those of thyroglobulin with an iodine content of less than 1%, hormonal iodine of 20-40% and carbohydrate content of less than 10%. The amino acid composition of the hagfish iodoprotein, especially the cysteine content of less than 1%, was also entirely different from that of thyroglobulin. These results suggest that most, if not all, tyrosine residues of the hagfish thyroid glycoprotein with a less rigid structure are susceptible to an iodinating system, but hormone residues are formed by a much less efficient mechanism than those in thyroglobulin, when poorly iodinated.

Stopped-flow--photometric and kinetic--fluorimetric methods for the determination of thyroid hormones in tablets

The catalytic effect of thyroxine and triiodothyronine on the reaction between cerium(IV) and arsenic(III) was studied by using photometric and fluorimetric measurements. The kinetic - photometric studies were based on measurement of the decrease in absorbance of cerium(IV), whereas the rate of formation of fluorescent cerium(III) was measured in the kinetic - fluorimetric studies. A modular stopped-flow system was coupled to a spectrophotometer in order to develop stopped-flow methods for the determination of thyroxine and triiodothyronine. The proposed methods were compared and applied to the determination of these hormones in pharmaceutical preparations.

Rhodamine B-labeled thyroid hormone forms high molecular weight aggregates in solution: a possible source of artifacts in binding experiments

The fluorescence intensity of rhodamine B-labeled thyroid hormone is a nonlinear function of probe concentration. The concentration dependence was analyzed in terms of a model with continuous aggregation of the probe molecules to give very high molecular weight species. The apparent association constant was 3.65 microM-1 at 25 degrees C, pH 7.2. Studies at different temperatures showed apparent delta H = 6.8 kcal/mol and delta S = -7.3 cal/mol/degree for association. Based on their absorbance spectra, these aggregates seem to be linear, with the rhodamine chromophores slanted with respect to the long axis.

[Evaluation of the diagnostic efficacy of a radioimmunologic assay: the example of thyroid tests]

Optimization of the utilization of a new radioimmunoassay (RIA) requires the identification of explicit criteria regarding when this new RIA should be used. The first step consists in the definition of the normal range on a well defined learning sample of patients. The authors describe the methods which can be used; mean and standard deviation, ROC analysis, Bayes theorem. These limits must be therefore validated on a control sample. The second step of this diagnostic evaluation must estimate the impact of the new RIA on the medical decision procedure. The historical account of thyroid function testing illustrates these different points.

Developmental changes in rat brain 5'-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones

We have studied the ontogenesis of 5'-deiodinase (5'D) activity in rat brain during fetal life, its capacity to respond to maternal or fetal hypothyroidism, and its regulation by maternal thyroid hormones. Type II 5'D (5' D-II) activity increases 4-fold during the period studied (17 to 22 days of gestation), mainly between days 19 and 21. Fetal brain T4 concentrations increase in parallel with fetal plasma T4, whereas fetal brain T3 concentrations increase 18 times (days 17-21), six times more than would have been expected from the small increase in fetal plasma T3 levels. Maternal thyroidectomy did not affect 5'D-II activity or thyroid hormone concentrations in fetal brain (except brain T4 at 18 days of gestation). Fetal hypothyroidism, induced by giving a goitrogen (methimazole) to the mothers, depleted all fetal tissues studied, including the fetal thyroid, from thyroid hormones. By 19 days of gestation, the fetal brain was able to respond to hypothyroidism with a 3- to 5-fold increase in 5'D-II activity. Earlier onset of treatment with methimazole led to 2- to 3-fold increases in 5'D already at 17 and 18 days of gestation, showing that when fetal thyroid secretion starts the fetal brain 5'D-II is able to respond to hypothyroidism. Replacement of methimazole-treated mothers with physiological doses of T4, given by constant infusion, increased T4 and T3 concentrations in fetal brain, and inhibited fetal, as well as maternal, brain 5'D-II activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Hormone-containing peptides from normal and goiter human thyroglobulins

A series of low iodine human thyroglobulin samples derived from colloid-rich goiter tissue was examined by HPLC mapping of tryptic digests and compared to normal human thyroglobulin. These samples ranged in iodine content from 2 to 8 gram-atoms of iodine (g.a. I) per mole and were not further iodinated in vitro. Peptides containing the principal hormonogenic sequence were detected using the long wavelength absorbance of the iodotyrosine derivatives at 325 nm. Two such peptides were isolated and sequenced. Their thyroxine content was confirmed by radioimmunoassay. The number of 325-nm-absorbing peaks was significantly lower in the normally iodinated human thyroglobulin than that observed the thyroglobulins of cattle and dog. This suggests a more restricted iodination in the human protein. Sodium dodecyl sulfate gel patterns of the reduced and alkylated proteins showed significant molecular size heterogeneity in all of the samples. Polypeptide fragments ranged in molecular size from approximately 330 to 45 kDa in the goiter derived material and from approximately 330 to 15 kDa in the normal human material. This difference between the proteins is consistent with earlier observations that peptides less than 45 kDa appear concomitantly with hormone formation. These data confirm that the human thyroglobulin molecule is capable of forming at least limited amounts of thyroid hormone at iodine levels as low as 4 g.a. I per mole. The hormone detected in this study was located at residue 5 near the amino terminus of the thyroglobulin molecule.

Computerized quality control of radioimmunoassay in Korea

Automated data processing and quality control of radioimmunoassays offer not only increased speed but also a more thorough and statistically rigorous analysis of results. An external quality assessment scheme for serum thyroxine, triiodothyronine and thyroid stimulating hormone (TSH) assays was performed in five nuclear medicine laboratories in Korea to compare with the assay performances of the World Health Organization Radioimmunoassay Program. The required radioimmunoassay kits were supplied through the International Atomic Energy Agency (IAEA). We have determined the weighted root mean squared error, and variance ratio as the indices of standard curve and also the average batch coefficient of variation (ABCV) as the parameters of response error relationship curve and precision profile. There was a good fit for the triiodothyronine assay, but 3 of 5 laboratories showed possible bad fit in the T4 and TSH assay systems. The ABCV was less than 5 percent for the T3 and T4 assay system, however for the TSH system, only 1 laboratory showed the ABCV value of less than 5 percent. We have also calculated the within batch variation (drift) and between laboratory variations.

Thyroid angiogenesis: endotheliotropic chemoattractant activity from rat thyroid cells in culture

Thyroid enlargement in response to chronic hypersecretion of TSH reflects the coordinated growth of both parenchyma and stroma. Because Wollman et al. observed in propylthiouracil-fed rats that enlargement and remodeling of thyroid capillaries were strictly localized around follicles, they hypothesized that growth of perifollicular blood vessels is stimulated by angiogenic factors secreted by neighboring follicular epithelial cells. In support of this hypothesis, we report that media conditioned by rat thyroid cells were very active in an in vitro angiogenesis bioassay that measures stimulation of endothelial cell migration through chemotaxis membranes in microwell Boyden chamber assemblies. Primary cultures of thyroid cells from collagenase-dispersed glands from male or female Holtzman rats fed 0.01% propylthiouracil in the drinking water released activity that produced up to 5-fold increases in endothelial cell migration rates relative to those in identical unconditioned medium. Thyroid-derived activity was primarily chemotactic (i.e. only weakly chemokinetic) to both rabbit aortic and microvascular endothelial cells. That endotheliotropic activity is derived from thyroid parenchyma is indicated by the finding that media conditioned by FRTL cells, a clonally derived thyroid follicular epithelial cell line, produced parallel chemoattractant responses. Thyroid-conditioned media were also chemoattractant to mouse BALB/c-3T3 cells, which have endothelial cell characteristics. In contrast, thyroid-conditioned media did not increase the high spontaneous migration rate of Walker rat sarcoma (WR256) cells. T4, T3, thyroglobulin, bovine fibroblast growth factor (alpha and beta), and media conditioned by rabbit endothelial cells were inactive. Chemoattractant activity in serum containing conditioned media was retained by both 10,000 and 30,000 mol wt cut-off (MWCO) ultrafilters. Activity in serum-free thyroid-conditioned media was largely retained by 10,000 MWCO filters, but only partially retained by 30,000 MWCO filters; activity in the 30,000 filtrate was recoverable in a 10,000 MWCO retentate. These findings support the hypothesis that capillary growth during thyroid enlargement occurs, at least in part, as a result of a parenchymal-stromal (epithelial-mesenchymal) paracrine interaction mediated by specific endotheliotropic (angiogenic) factors released by follicular epithelial cells and distinct from T3, T4, and thyroglobulin.

Immunoelectron microscopic demonstration of thyroglobulin and thyroid hormones in rat thyroid gland

We have developed a post-embedding immunogold technique for electron microscopic localization and quantitation of thyroglobulin (TG), thyroxine (T4), and triiodothyronine (T3) in rat thyroid. Labeling for TG was located on rough endoplasmic reticulum, Golgi apparatus, exocytotic vesicles, luminal colloid, colloid droplets, and lysosomes, whereas labeling for thyroid hormones was located on luminal colloid, colloid droplets, and lysosomes. We tested different procedures of fixation, dehydration, embedding, polymerization, and immunoincubation to optimize ultrastructural preservation and immunolabeling. Fixation with glutaraldehyde and osmium was possible with retained antigenicity. Dehydration temperature and the choice of embedding resin were the two crucial factors for good immunolabeling. Low-temperature dehydration greatly improved immunolabeling and could be combined with embedding in the methacrylate LR White or the epoxide Agar 100 (equivalent of Epon 812) polymerized at 40-60 degrees C, as the temperature during subsequent embedding and polymerization was of little importance for the immunoreactivity. Labeling on LR White sections was always higher than on Agar 100 sections. Various etching procedures were tested without improved specific labeling. Etching with hydrochloric acid gave nonspecific labeling of certain cell compartments.

An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef

We report an outbreak of thyrotoxicosis without true hyperthyroidism that occurred between April 1984 and August 1985 among residents of southwestern Minnesota and adjacent areas of South Dakota and Iowa. One hundred twenty-one cases were identified through surveillance of medical clinics, laboratories, hospitals, and physicians' offices. Investigation of the outbreak demonstrated an association between the occurrence of thyrotoxicosis and the consumption of ground beef prepared from neck trimmings processed by a single slaughtering plant (odds ratio, 19.0; P = 0.0001). The cause was confirmed by the findings of bovine thyroid tissue in samples of these trimmings and high concentrations of thyroid hormone in implicated samples of ground beef and the demonstration of prompt increases in serum thyroid hormone concentrations in volunteers who ate the implicated ground beef. Bovine thyroid tissue had been introduced into the neck trimmings inadvertently during the process of "gullet trimming," a procedure that harvests muscles from the bovine larynx. The outbreak resolved after this procedure was discontinued at the plant. The clinical features of the illness suggested the diagnosis of silent thyroiditis, and it is possible that sporadic cases--or even outbreaks--of thyrotoxicosis factitia caused by this mechanism may have occurred in the past but were not recognized.

Concentration of thyroid hormones and prolactin in dairy cattle serum and milk at three stages of lactation

Eighteen lactating Holstein cows were used with six each in early, mid, and late lactation. Blood samples were obtained on 7 successive d. Blood serum and milk were measured by radioimmunoassay for thyroxine, 3,5,3'-triiodothyronine, and 3,3',5'-triiodothyronine. Prolactin was also measured in serum by radioimmunoassay. Serum thyroxine increased as lactation progressed and milk production declined (50, 55, and 62 ng/ml). Serum concentrations of triiodothyronine and reverse triiodothyronine were unchanged throughout lactation. Prolactin in serum declined as lactation advanced linearly (14.4, 11.8, and 10.5 ng/ml). Concentrations of thyroxine and triiodothyronine in milk declined significantly between early and mid but not mid and late lactation. Reverse triiodothyronine in milk did not change over the lactation. Serum triiodothyronine contained 1200 to 1300 pg/ml, whereas that in milk was 200 to 300 pg/ml. Reverse triiodothyronine was over 300 pg/ml in serum and only 80 to 90 pg/ml in milk. Amounts of thyroxine and triiodothyronine available to offspring from milk were calculated to be minor sources (4 to 5%) of total requirements for maintenance of metabolic function.

[Role of breast feeding in providing the newborn infant with thyroid hormones]

Radioimmunoassay was conducted to study the content of triiodothyronine and thyroxine in the human milk and in the blood serum of mature and premature newborns. It was established that with the growth of the lactation period the content of triiodothyronine and thyroxine rose; it was, respectively, 0.5 +/- 0.12 and 100.3 +/- 8.4 nmol/l in colostrum, 9.2 +/- 0.7 and 271.3 +/- 14.1 nmol/l in transient milk, 11.1 +/- 1.07 and 405.0 +/- 21.4 nmol/l in fully formed milk. Fully formed milk contains three times more triiodothyronine and thyroxine than the blood serum of newborns. The mature newborns have a sufficiently formed thyroid function. The level of thyroid hormones in the blood serum of premature newborns is decreased in proportion to the stage of their prematurity. They receive the deficient hormones through the human milk. The authors recommend that the nutrition of premature newborns receiving mixed and artificial feeding should be supplemented with thyroid hormones.